Abbreviations ACT adoptive cell therapy AFP alpha-fetoprotein ALT alanine aminotransferase AST aspartate aminotransferase BCLC barcelona clinic liver cancer CAR chimeric antigen receptor CBA cytometric bead array CCR C-C chemokine receptor CD cluster of differentiation CHB chronic hepatitis B CNLC China liver cancer CRP C-reactive protein CRS cytokine release syndrome Cy/Flu cyclophosphamide plus fludarabine CT computed tomography DLT dose-limiting toxicity DNA deoxyribonucleic acid E:T effector to target ratio ECOG eastern cooperative oncology group GMP good manufacturing practice Gt genotype HBcAg hepatitis B core antigen HBeAg hepatitis B e antigen HBsAg hepatitis B surface antigen HBV hepatitis B virus HCC hepatocellular carcinoma HLA human leukocyte antigen IFN- interferon-gamma IL interleukin INR international normalized ratio iRECIST immune Response Evaluation Criteria in Solid Tumors LD lymphodepletion LHD lactate dehydrogenase MHC major histocompatibility complex mRECIST modified Response Evaluation Criteria in Solid Tumors NPG NOD-Cg-PrkdcSCIDIL-2Rgcnull/vst qPCR quantitative polymerase chain reaction RNA ribonucleic acid RTCA real time cell analysis SAE serious adverse event S 20 amino acid position 20 of the HBV S protein TCR T cell receptor TCR-T T cell receptor T cells TNF- tumor necrosis factor- TRAE treatment related adverse event ULN upper limit of normal UT untransduced T cells Study Highlights Patient-derived T cells can be manufactured via lentiviral transduction under GMP conditions to express an HBV-specific TCR

Clin Chem 36 : 297303 Roe CR, Cederbaum SD, Roe DS, Mardach R, Galindo A, Sweetman L 1998 Isolated isobutyryl-CoA dehydrogenase deficiency: an unrecognized defect in human valine metabolism
The pathogenesis of ischemia reperfusion injury begins with a hypoxic insult to the vascular endothelium which further demonstrates protective responses [28]
- Medical treatments to improve cognitive function, reduce muscle damage, and improve heart and muscle function in people with various heart diseases
The lack of mutual dialogue with society, local institutions, and civil society organizations prevents power sharing between institutions